Oral ulcer associated with alendronate: A case report

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 110, Issue 6, 2010, Pages

  Kharazmi, Mohammad ^a   Sjqvist, Kerstin ^a   Rizk, Milad ^a   Warfvinge, Gunnar ^b  

^a Central Hospital   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; ATROPHY; BIOPSY; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; EPITHELIUM; FEMALE; FOLLOW UP; HUMAN; LIP DISEASE; MOUTH MUCOSA; MOUTH ULCER; PATHOLOGY; STOMATITIS; TONGUE DISEASE;

AGED, 80 AND OVER; ALENDRONATE; ATROPHY; BIOPSY; BONE DENSITY CONSERVATION AGENTS; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIP DISEASES; MOUTH MUCOSA; ORAL ULCER; STOMATITIS; TONGUE DISEASES;

EID: 78649522527     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.04.035     Document Type: Article

References (24)

1. P.C. de Groen, D.F. Lubbe, L.J. Hirsch, A. Daifotis, W. Stephenson, and D. Freedholm Esophagitis associated with the use of alendronate N Engl J Med 335 1996 1016 1021
2. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
3. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
4. A. Spreux, M. Amples, G. Bolla, and B. Baldin Ulceration muqueuses topographique atypiques avec l'alendronate Therapie 53 1998 182 192
5. N. Demerjian, G. Bolla, and A. Spreux Severe oral ulcerations induced by alendronate Clin Rheumatol 18 1999 349 350
6. M.A. Gonzalez-Moles, and J.V. Bagan-Sebastian Alendronate-related oral mucosa ulcerations J Oral Pathol Med 29 2000 514 518
7. J. Schmutz, A. Barbaud, and P. Trchot Monosodium alendronate Ann Dermatol Venereol 127 2000 1138
8. K. Krasagakis, S. Krger-Krasagakis, D. Ioannidou, and A. Tosca Chronic erosive and ulcerative oral lesions caused by incorrect administration of alendronate J Am Acad Dermatol 50 2004 651 652
9. J.L. Schmutz, A. Barbaud, and P. Trechot Alendronate and mouth ulcers: careful interrogation of the patient to start with Ann Dermatol Venereol 132 2005 930
10. N. Ponte Fernndez, R. Estefania Fresco, and J.M. Aguirre Urizar Bisphosphonates and oral pathology I General and preventive aspects Med Oral Patol Oral Cir Bucal 11 2006 E396 E400
11. P. Rubegni, and M. Fimiani Images in clinical medicine Bisphosphonate-associated contact stomatitis N Engl J Med 355 2006 e25
12. A. Dicko, A. Toulemonde, F. Hoareau, M. Avenel-Audran, and J.L. Verret Mouth ulcers Ann Dermatol Venereol 134 2007 389 390
13. F. Cardona Tortajada, E. Sainz Gmez, J. Figuerido Garmendia, and A. Lirn de Robles Adsuar Chronic mouth ulcer due to inadequate ingestion of alendronate Aten Primaria 40 2008 430 431
14. W. Aleid, and A. Sidebottom Oral mucosal irritation with incorrect use of alendronate Br J Oral Maxillofac Surg 47 2009 170 171
15. M. Garca-Font, N. Curc, C. Prat, and P. Vives Mouth sores caused by alendronate Actas Dermosifiliogr 100 2009 77 78
16. S.N. Elliott, W. McKnight, N.M. Davies, W.K. MacNaughton, and J.L. Wallace Alendronate induces gastric injury and delays ulcer healing in rodents Life Sci 62 1998 77 91
17. A.A. Reszka, J. Halasy-Nagy, and G.A. Rodan Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation Mol Pharmacol 59 2001 193 202
18. M.J. Rogers New insights into the molecular mechanisms of action of bisphosphonates Curr Pharm Des 9 2003 2643 2658
19. T. Schnitzer, H.G. Bone, G. Crepaldi, S. Adami, M. McClung, and D. Kiel Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis Alendronate Once-Weekly Study Group Aging (Milano) 12 2000 1 12
20. K. Kanatsu, E. Aihara, M. Okayama, S. Kato, and K. Takeuchi Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate J Gastroenterol Hepatol 19 2004 512 520
21. M.A. Blank, B.L. Ems, G.W. Gibson, W.R. Myers, S.K. Berman, and R.J. Phipps Nonclinical model for assessing gastric effects of bisphosphonates Dig Dis Sci 42 1997 281 288
22. F.L. Lanza, R.H. Hunt, A.B. Thomson, J.M. Provenza, and M.A. Blank Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women Gastroenterology 119 2000 631 638
23. R.E. Marx Clinical concerns of alendronate use J Oral Maxillofac Surg 66 2008 1322
24. Adverse Drug Reactions Committee (ADRAC) A gut feeling for alendronate Aust Adv Drug React Bull 18 1999 11